Literature DB >> 21029944

Surgery for isolated liver metastasis of ovarian cancer.

Salih Pekmezci1, Kaya Saribeyoglu, Erman Aytac, Macit Arvas, Fuat Demirkiran, Mustafa Ozguroglu.   

Abstract

BACKGROUND: Few studies have been published on liver resection alone or in combination with cytoreductive surgery for liver metastases of ovarian carcinoma.
METHODS: Eight patients who underwent liver resection for metastasis of ovarian cancer were included in the study. Total abdominal hysterectomy and bilateral salpingo-oophorectomy had been performed before liver surgery in all patients. The demographic data, follow-up details before and after liver resection, histopathology of the primary ovarian cancer, type of surgery and outcome were evaluated.
RESULTS: The mean age of the patients was 56.1 (46-68) years. The mean hospitalization time was 8 (7-10) days. The mean disease-free interval was 5.38 years from the time of initial surgery to surgery for metastatic liver lesions, and 39 months after liver resection to secondary metastases. Four patients did not have any evidence of disease after liver surgery.
CONCLUSION: Indications for liver resection should be considered in selected patients who have a limited extent of metastatic disease from ovarian carcinoma. Liver resection for metastases of ovarian carcinoma could be an effective and feasible approach.
Copyright © 2010 Asian Surgical Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21029944     DOI: 10.1016/S1015-9584(10)60014-0

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  4 in total

Review 1.  Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.

Authors:  Maria Luisa Gasparri; Giovanni Grandi; Daniele Bolla; Beat Gloor; Sara Imboden; Pierluigi Benedetti Panici; Michael D Mueller; Andrea Papadia
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-11       Impact factor: 4.553

2.  Nomogram Models for Predicting Risk and Prognosis of Newly Diagnosed Ovarian Cancer Patients with Liver Metastases - A Large Population-Based Real-World Study.

Authors:  Gui-Min Hou; Chuang Jiang; Jin-Peng Du; Chang Liu; Xiang-Zheng Chen; Ke-Fei Yuan; Hong Wu; Yong Zeng
Journal:  J Cancer       Date:  2021-10-25       Impact factor: 4.207

3.  Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer.

Authors:  Guang-Cai Niu; Chang-Ming Shen; Wei Cui; Qiang Li
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

4.  Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.

Authors:  Nicolae Bacalbasa; Simona Dima; Vladislav Brasoveanu; Leonard David; Irina Balescu; Raluca Purnichescu-Purtan; Irinel Popescu
Journal:  World J Surg Oncol       Date:  2015-08-05       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.